These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4218940)

  • 1. [Clomethacillin. Synthesis and antibacterial properties].
    Rudzit EA; Pleshakov MG; Radkevich TP; Kulikova DA; Avidon VV
    Antibiotiki; 1974 Oct; 19(10):887-90. PubMed ID: 4218940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA; Shapovalova SP; Malkova IV
    Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
    Shorin VA; Shapovalova SP
    Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904
    [No Abstract]   [Full Text] [Related]  

  • 5. Pirazocillin: a new acid and penicillinase resistant semisynthetic penicillin.
    Koczka I; Badár E; Kerényi S; Osz E
    Acta Microbiol Acad Sci Hung; 1974; 21(3-4):359-79. PubMed ID: 4215296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lincomycin--a new antibiotic].
    Primavesi CA
    Arzneimittelforschung; 1967 Apr; 17(4):500-2. PubMed ID: 4386772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlation between structure and antibacterial activity in a series of azo derivatives of salicylic and alpha-oxynaphtholic acid].
    Rudzit ZA; Mukhina NA; Galanova RIa; Kivman GIa
    Farmakol Toksikol; 1969; 32(4):449-51. PubMed ID: 4391081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
    Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
    Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the combined effect of various penicillins].
    Simon C
    Chemotherapy; 1966; 11(2):104-10. PubMed ID: 5333691
    [No Abstract]   [Full Text] [Related]  

  • 10. [Penicillin G and its derivatives. Preparation, dosage, current indications and complications].
    Hemmer R; Waldvogel FA
    Rev Prat; 1977 Oct; 27(43):2777-87. PubMed ID: 337454
    [No Abstract]   [Full Text] [Related]  

  • 11. Duration of therapeutic activity of aminoalicyclic penicillins against bacterial infections in mice.
    Hopper MW; Yurchenco JA; Warren GH
    Antimicrob Agents Chemother (Bethesda); 1967; 7():597-601. PubMed ID: 5596196
    [No Abstract]   [Full Text] [Related]  

  • 12. Terpene compounds as drugs. 8. Bacteriological and pharmacological properties of terpenyl penicillins.
    Pala G; Casadio S; Coppi G; Crescenzi E; Mantegani A
    Arzneimittelforschung; 1970 Jan; 20(1):62-8. PubMed ID: 4986283
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative microbiological study of some polysynthetic penicillins].
    Morozov BA
    Antibiotiki; 1969 Jan; 14(1):27-30. PubMed ID: 4976742
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of cellular lipid in the resistance of gram-positive bacteria to penicillins.
    Hugo WB; Stretton RJ
    J Gen Microbiol; 1966 Jan; 42(1):133-8. PubMed ID: 4958940
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro and in vivo activity of a new semisynthetic penicillin: flucloxacillin].
    Renzini G; Bevilacqua R; Oliva B; Ravagnan G
    Farmaco Sci; 1973 Sep; 28(9):733-40. PubMed ID: 4749859
    [No Abstract]   [Full Text] [Related]  

  • 16. [Microbiological and chemotherapeutic study of the antibiotic mutabilicin].
    Perrova MA; Shneerson AN; Tebiakina AE; Navashin SM; Braginskaia PS
    Antibiotiki; 1967 May; 12(5):404-6. PubMed ID: 4385808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically useful antimicrobial agents. Selection of regimen.
    Postgrad Med; 1967 Nov; 42(5):420-33. PubMed ID: 6055006
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance.
    Goto S; Kuwahara S; Okubo N; Zenyoji H
    J Antibiot (Tokyo); 1968 Feb; 21(2):119-25. PubMed ID: 4299887
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
    Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
    Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.